Pfizer
PFE· Manufacturing· Fiscal year ends in December
CEO pay in FY2024
A. Bourla is the CEO of Pfizer and was paid $24.6M in FY2024 (Dec), up 14%.
PayNo stock prices for these years
Executives6
See all- 1A. BourlaChairman and Chief Executive OfficerFY2024
- 2A. MalikChief U.S. Commercial Officer, EVPFY2025
- 3D. DentonChief Financial Officer, EVPFY2024
- 4C. BoshoffChief Scientific Officer and President, Research & DevelopmentFY2024
- 5D. LanklerGeneral Counsel, EVPFY2024
- 6Albert Bourla, DVM, Ph.D.DirectorNot disclosed
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allPfizer paid its one named executive on file $9.4M in FY2025 (Dec).
| Name | |||
|---|---|---|---|
| A. MalikChief U.S. Commercial Officer, EVP | |||
| A. BourlaChairman and Chief Executive Officer | Not disclosed | ||
| D. DentonChief Financial Officer, EVP | Not disclosed | ||
| C. BoshoffChief Scientific Officer and President, Research & Development | Not disclosed | Not disclosed | |
| D. LanklerGeneral Counsel, EVP | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers11
See allThe FY2015 (Dec) proxy of Pfizer names 11 peer companies for pay. Pay versus performance data of Pfizer for that year is not on file, so it has no rank.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board1
See all- Shantanu NarayenLead independent director · 12 yr on the boardIndependent—Paid as an executive
The board of the latest proxy (FY2025).
Shared directors
- AdobeShantanu Narayen1 shared
Activity
Filings24
See all| Current report | 8-K | Jun 18, 2026 | — |
| Current report | 8-K | Apr 27, 2026 | — |
| Proxy statement | DEF 14A | Mar 12, 2026 | FY2025 |
| Annual report | 10-K | Feb 26, 2026 | FY2025 |
| Current report | 8-K | Apr 28, 2025 | — |
| Proxy statement | DEF 14A | Mar 13, 2025 | FY2024 |
